Answers are grounded in this paper and cite their sources.
2-Aminothiazole and compounds with terminal phenoxy groups are privileged structures in medicinal chemistry. Compounds containing these two scaffolds are of interest for the design of new pharmaceuticals, particularly for treating malignant tumors. Hybridization, which is realized by combining both privileged fragments via the formation of covalent bonds, is a promising approach to finding lead compounds. The resulting conjugates can bind to a variety of receptors, and therefore, their synthesis and pharmacological screening is an actual task of modern medicinal chemistry. This review highlights the latest advances in the field of phenoxyalkylacylamino thiazoles and their analogs with anticancer potential, covering work published over the past two decades.
No takes yet. Share an insight, caveat, or question.
Matiichuk et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: